Showing results (71-80 of 89) with videos related to
Sort By:
Pageof 9
Virology|November 1, 2008
Insertion of the CXC chemokine ligand 9 (CXCL9) into the mouse hepatitis virus genome results in protection from viral-induced encephalitis and hepatitisMichael Muse, Joy A C Kane, Daniel J J Carr, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 2, 2017
The Neonatal Fc Receptor and Complement Fixation Facilitate Prophylactic Vaccine-Mediated Humoral Protection against Viral Infection in the Ocular MucosaDerek J Royer, Meghan M Carr, Hem R Gurung, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 18, 2006
OAS and PKR are not required for the antiviral effect of Ad:IFN-gamma against acute HSV-1 in primary trigeminal ganglia culturesBobbie Ann Austin, William Halford, Robert H Silverman, et al.Vaccines|April 3, 2021
Assessment of Two Novel Live-Attenuated Vaccine Candidates for Herpes Simplex Virus 2 (HSV-2) in Guinea PigsJonathan D Joyce, Anant K Patel, Brandie Murphy, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|October 25, 2002
Absence of PKR attenuates the anti-HSV-1 activity of an adenoviral vector expressing murine IFN-betaKhaldun Al-Khatib, Bryan R G Williams, Robert H Silverman, et al.Journal of Virology|January 27, 2017
Impact of Type I Interferon on the Safety and Immunogenicity of an Experimental Live-Attenuated Herpes Simplex Virus 1 Vaccine in MiceDerek J Royer, Meghan M Carr, Ana J Chucair-Elliott, et al.Glia|May 9, 2014
Microglia-induced IL-6 protects against neuronal loss following HSV-1 infection of neural progenitor cellsAna J Chucair-Elliott, Christopher Conrady, Min Zheng, et al.Advances in Experimental Medicine and Biology|March 26, 2014
Sphingolipids in ocular inflammationAnnie Y Chan, Shivani N Mann, Hui Chen, et al.Journal of Virology|June 7, 2002
Differential effect of murine alpha/beta interferon transgenes on antagonization of herpes simplex virus type 1 replicationPeter Härle, Vanessa Cull, Martin-Paul Agbaga, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2013
Microglia and a functional type I IFN pathway are required to counter HSV-1-driven brain lateral ventricle enlargement and encephalitisChristopher D Conrady, Min Zheng, Nico van Rooijen, et al.Pageof 9